Salarius Pharmaceuticals, Inc. Soared

Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ) rocketted at $3.67, representing a gain of 135.3%. On Mon, Jan 13, 2025, SLRX:NASDAQ hit a New 2-Week High of $3.67. The stock got featured on our News Catalysts scanner on Mon, Jan 13, 2025 at 10:35 AM in the 'AGREEMENT' category. From Mon, Dec 30, 2024, the stock recorded 37.50% Up Days and 33.33% Green Days

The stock spiked on Mon, Jan 13, 2025 at $7.2 with a volume of 120M+.

About Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ)

Flex Pharma Inc is a US-based biotechnology company which is engaged in the developing proprietary treatments for muscle cramps and spasms associated with severe neurological conditions and exercise-associated muscle cramps. The lead drug product candidate is FLX-787 which is a single molecule, chemically synthesized, TRP ion channel activator and HOTSHOT, which is developed to prevent and treat exercise-associated muscle cramps. It operates through two segments - Consumer Operations and Drug Development. The Consumer Operations segment includes the development of HOTSHOT whereas the Drug Development segment includes the development of proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions.